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(engagement or measurement) and the focus of the article (health care, research, 
or teaching). Results: Our search identified 5051 publications from 1966-2013. We 
found a steep increase in the term’s use in recent decades. In the 1960s, ‘70s, and 
‘80s, < 50 articles were identified per decade. The number increased to > 350 in the 
90s, > 1550 in the 2000s and > 3000 in the 2010s. The vast majority (> 80%) of publica-
tions from the 1960s-2009 focused on patient engagement. However, from 2010-2013, 
the focus was equally split between engagement and measurement of PROs. From 
1966-2013, articles reporting original research increased from 17% to 90%. In early 
decades, qualitative research proliferated, whereas research since 2010 employed 
more quantitative epidemiological methods. There was also a notable shift from a 
single-disciplinary approach in the early decades to a multidisciplinary approach in 
the later decades. ConClusions: Since its introduction in scientific literature, the 
term patient-centered has flourished, with tremendous increases noted in the last 
decade. The concept has evolved from purely patient engagement to encompass both 
engagement and measurement of PROs and from qualitative to more rigorous scien-
tific methods. These findings are congruent with the current personalized-medicine 
approach that characterizes the health care industry today.
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An AnAlysIs Of HcAHPs scOrIng And THe ImPAcT Of THe PAIn 
mAnAgemenT dImensIOn On HOsPITAl PerfOrmAnce
Abraham J.1, Jones J.2, Baker G.1, Arpino P.1
1The Medicines Company, Waltham, MA, USA, 2The Medicines Company, Parsippany, NJ, USA
objeCtives: The Hospital Consumer Assessment of Healthcare Providers and 
Systems (HCAHPS) survey captures patient satisfaction across 8 dimensions. CMS 
compares a facility’s most positive rating in each dimension (“top-box”) against 
three scores calculated from the national sample during a baseline period. Pain 
management is the only HCAHPS dimension directly related to a patient’s medical 
condition while concurrently influencing overall patient experience and satisfac-
tion. This study utilizes CMS data and HCAPHS survey results to evaluate current 
HCAHPS pain measures across facilities, and the potential benefit to overall HCAHPS 
scores by improving pain management in an inpatient setting. Methods: Baseline 
scores (low, middle, and high) from FY2013 through FY2016 were collected and 
evaluated for trends and impact on performance scores. A set of hospitals was 
selected based on participation in CMS data collection and HCAHPS survey admin-
istration. The average hospital domain scores were tabulated for all 8 dimensions 
for FY2013 and FY2014. A direct comparison was made between the changes in pain 
management dimension and all other dimensions. Results: Between FY2013 and 
FY2014 the pain management middle and high baseline scores will increase by 0.3% 
and 0.03% while the other 7 dimensions will increase on average, 1.0% and 0.4% 
respectively. Mean “top-box “ratings between FY2013-2014 changed by less than 
1% across all dimensions. The disparity in baseline scores over the same period 
led to a change in pain dimension scores by 3%, while the other 7 dimensions saw 
performance scores change in the range of 2% - > 10%. ConClusions: This analysis 
illustrates that changes to the baseline scores may have a significant impact on 
HCAHPS performance scores. As a result, proportional improvement in pain scores 
will disproportionately increase overall HCAHPS scores compared with the other 
7 dimensions, indicating an increased importance of adequate pain management 
on overall patient satisfaction and Medicare payment.
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IncludIng PATIenTs’ Preferences In THe decIsIOn mAkIng PrOcess TO 
deTermIne THe cOnTenT Of HeAlTH BenefIT PlAns: A nArrATIve revIew
Moreno-Mattar O., Mejia A.
Instituto De Evaluación Tecnológica En Salud - Iets, Bogota, Colombia
objeCtives: Identify the main methodologies used to include patients’ prefer-
ences in the decision making process to determine the content of health benefit 
plans. Methods: We systematically searched electronic databases (MEDLINE, 
EMBASE, The Campbell Collaboration, JStor, Health System Evidence, DoPHER and 
LILACS) for studies that were published from the inception of the databases to 
September 16 2013. We excluded editorials, letters to the editor, communications, 
abstracts and any article related to preferences for particular technologies or stud-
ies describing decisions about specific diseases. Results: We found 1.868 non-
duplicate citations in the electronic search; 33 were assessed for eligibility and 
finally, 12 studies were included in the analysis (3 reviews and 9 individual studies). 
The reviews concluded that it is important to use simple, objective and inclusive 
methods to include patients’ preferences in decision making processes but don’t 
recommend any specific methodology. The other studies used methodologies favor-
ing public engagement and public participation, citizens’ jury, conjoint analysis, 
discrete choice experiment method and CHAT (Choosing Healthplans All Together). 
These studies were mainly conducted in High Income Countries (United States, 
Germany, Canada, UK and Hungary). CHAT was the methodology most commonly 
used because it is an exercise that patients understand easily, and researchers 
recognize as practical and objective. ConClusions: There is a growing interest 
in public engagement in priority setting in health. The methods and characteris-
tics of the studies evaluating methodologies used to include patients’ preferences 
in the decision making process to determine the content of health benefit plans 
varied, and it is difficult to make comparisons. Some methodologies such as con-
joint analysis methods might need more time to develop. Researchers believe it is 
important that the methodologies are easy for patients to understand to facilitate 
their participation.
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objeCtives: The study determines socio-economic factors that influence the likeli-
hood of a married woman in Indonesia on contraceptive choice. Methods: The 
given no instruction whether to consider income. Two studies reported significantly 
lower proportions (Sweden: 4%; United States: 15%), while 1 study a higher propor-
tion (Japan: 77%). Differences in study population (students versus general), health 
state severity, and utility elicitation method (time trade off versus visual analogue 
scale) may explain conflicting results. The impact of cultural attitudes towards work 
and the social security net (e.g. wage replacement rates) is not clear. No published 
studies shed light on whether respondents consider income loss when assigning 
utilities to the EQ-5D or other widely-used generic health tariffs. ConClusions: 
In many studies reviewed, a large proportion of respondents stated that they did 
not consider income loss during utility elicitation, suggesting income loss is not 
fully captured in health state valuations. Further research is needed to determine 
whether productivity losses are fully captured in QoL measurements for health 
scales such as the EQ-5D, or if the economic value of work loss should be included 
explicitly in cost-effectiveness analyses.
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swITcHIng drugs: ecOnOmIc And clInIcAl OuTcOmes
Al Ameri M.
Zayed Military Hospital Camp, Abu Dhabi, United Arab Emirates
objeCtives: This paper explores some ethical issues that may arise in the con-
text of generic and therapeutic substitution by evaluating patients’ awareness and 
understanding of drug substitution. Methods: A literature review and a survey 
of a total of 163 patients using a questionnaire containing 36 questions. Results: 
Majority of patients had a kidney transplant for more than a year ago and were 
highly educated. Overall key findings concluded that 84% of patients were aware 
of the availability of generic medicines, 70% understood the term “generic” and 
“branded” in relation to medicines and 54% were aware of generic substitution 
practice. However, 75% did not know if they were taking generic medicines and 84% 
felt that generics were not equivalent or only equivalent sometimes, and they were 
uncertain that generics had the same quality as branded medicines. Of patients on 
generics, 66% were dissatisfied or uncertain about their satisfaction concerning 
generic medicines and 55% experienced noticeable differences between the branded 
and generic medicines mostly in the packaging, shape, colour or taste and felt that 
the branded medicines are more effective than their counterpart generics. Of these, 
75% admitted that adapting to these differences was problematic. This practice has 
been considered ethical on the basis of the presumption that the cheaper drug is 
not inferior to the more expensive one and the premise that any saving that does 
not compromise the quality of care is ethical. Indeed, under such circumstances 
substitution raises no ethical problem whatsoever. ConClusions: Many patients 
are distrustful of generics because they consider these drugs as being less expensive, 
less effective and associated with increased adverse events. The lack of transparency 
around generic substitution is of concern and might lead to confusion or worry on 
the patients’ side. Promoting generic and therapeutic substitution on economic 
grounds alone is potentially dangerous and unethical.
PIH57
ATTrAcTIveness Of PrO mIxed mOdes – wHAT Are PATIenTs sAyIng?
Ross J., Holzbaur E.
Almac Clinical Technologies, Souderton, PA, USA
objeCtives: An important industry topic is the utilization of mixed PRO modes 
in clinical trials. Using mixed modes may be beneficial for sponsors, but there is a 
lack of evidence supporting that data from different modes renders equivalence 
across modes. Given the industry’s interest in mixed modes, a qualitative research 
investigation was done to see if patients would be accepting if mixed modes were 
introduced into clinical trials. Methods: A global internet-based survey was 
administered to patients who participated in at least 1 trial including patient diaries 
in the past 2 years. The survey included a qualitative section that asked patients 
to explain how attractive the option to utilize several different modes of patient 
diaries would be versus one mode alone in future trials. Responses were examined 
and placed into categories for analysis. Results: 346 patients provided analyzable 
responses. 67.1% indicated they favored multiple modes, 29.5% were against; 2.9% 
neutral, and 0.6% undecided. For those favoring mixed modes, 41.4% indicated that 
they liked options/choices, 19.4% indicated that it would be easier/more convenient, 
13.4% indicated being attracted to choosing their preferred mode, 12.9% indicated 
that it would allow for better access, and 12.9% found the flexibility to be attractive. 
For those who were against, 31.4% indicated that they preferred using one mode, 
28.4% were interested only in using their preferred mode, 20.6% indicated it would 
be confusing, and 19.6% indicated it would be more complicated. ConClusions: 
Results show that many patients would be accepting of mixed modes, but the 
acceptance is not unanimous. Mixed modes may be a part of future clinical studies 
if equivalence evidence is established. By examining responses of those against 
mixed modes, patients’ concerns can be identified and addressed. Common mes-
sages identified include keeping the modes easy to use and selecting proper choice 
of modes for administration.
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evOluTIOn Of THe PATIenT-cenTered cOncePT In THe PuBlIsHed 
lITerATure
Covington D.1, Veley K.M.2, O’Donnell H.B.3
1PPD, Wilmington , NC, USA, 2PPD, Morrisville, NC, USA, 3UNC Wilmington, Wilmington, NC, 
USA
objeCtives: In today’s health care arena, the term “patient-centered” is typically used 
to describe either: 1) the engagement of patients in managing their health or 2) the 
measurement of patient-reported outcomes (PROs). The objective of this study was 
to explore the evolution of the patient-centered concept as reported in the scientific 
literature. Methods: We searched EMBASE for articles written in English between 
1950-2013 with ‘patient-centered’ in the title or abstract. We examined trends in the 
concept’s use over time by graphing the number of publications by year. We selected 
a random sample of 10 articles within each decade and captured data on the context 
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objeCtives: From 2006 – 2013 the FDA approved 207 new molecular entities 
(NMEs), which included 84 efficacy statements supported by PRO assessments. In 
addition to NMEs, many previously-approved product labels were updated with 
PRO statements during this period. The purpose of this research was to review 
the efficacy claims supported by PROs to identify trends amongst the approved 
indications and differences between approved claims before and after finaliza-
tion of the guidance. Methods: NME labels approved by the FDA from 2006 – 
2013 were reviewed on the Drugs@FDA website; updated labels were discovered 
via literature and Internet searches. An assessment or statement of efficacy was 
considered to be PRO-based if it assessed symptoms, side effects, or impacts on 
functioning and daily activities, entirely from the patient perspective. Results: 
From 2006 – 2013, the FDA approved an average of 25.9 NMEs per year. The aver-
age number of PROs included in NME labels from 2006 – 2010 was 14.2 per year 
(n = 71). From 2011 – 2013, the average was 4.3 PROs approved per year (n = 13). 
The difference between these two periods is statistically significant (t = 4.85, p = 
.002). Further investigation revealed 22 non-NME labels with PROs newly approved 
during this period, with no notable per-year trends. ConClusions: The FDA’s 
PRO Guidance may not be the lone cause for the reduction of approved PROs in 
NME labels, but there was a significant drop in the number of approvals following 
its finalization. While the number of PROs approved in 2010 was similar to the 
numbers approved 2006 – 2009, submissions reviewed in 2010 may not have been 
asked to meet the standards of the PRO Guidance, thus impacting our analysis. 
Inclusion of non-NME labels approved from 2006 – 2013 does not increase the 
percentage of PROs approved.
PIH65
rIsk PercePTIOn Of medIcATIOn sIde effecTs: A PrOducT Of sIde effecT 
cHArAcTerIsTIcs, sTylIsTIc fAcTOrs Of THe cOmmunIcATed messAge 
Or BOTH?
Sawant R.V.1, Sansgiry S.S2, Beatty C.R.3
1University Of Houston, Houston, TX, USA, 2University of Houston, Houston, TX, USA, 3University 
of Houston College of Pharmacy, Houston, TX, USA
objeCtives: To evaluate effect of side effect characteristics (frequency and sever-
ity) and stylistic factors (plain language or plain language combined with numeric 
frequency) on risk perception of side effects. Methods: About 100 participants 
were randomly presented with four of eight conditions with information about 
medication side effects in a 2 (side effect frequency: low, high) X 2 (side effect 
severity: mild, severe) X 2 (communication style: plain language, plain language 
combined with numeric frequency) experimental design. The participants were 
then asked to rate their risk perception with each of the four conditions. Test for 
analysis of variance was performed. Results: As compared to plain language only, 
the use of combination of plain language and numeric frequencies to communicate 
side effect information lead to an increase in risk perception for mild side effects of 
high frequency (difference between mean risk perception scores = 25.30, p< 0.001). 
The mean risk perception scores did not differ significantly across the two com-
munication styles for severe side effects of high frequency, severe side effects of 
low frequency and mild side effects of low frequency. With plain language com-
munication style the difference between mean risk perception scores across two 
frequency levels was 42.68 (p< 0.001) for mild side effects whereas that for severe 
side effects was 61.59 (p< 0.001). Similar effects were seen with combination com-
munication style (mild side effects: difference between means= 70.34, p< 0.001; 
severe side effects: difference between means= 70.07, p< 0.001). With communica-
tion style and frequency kept constant, change in severity did not have any effect 
on the risk perception scores. ConClusions: Frequency of side effects play a major 
role in evaluation of personal risk of side effects. Stylistic factors also affect risk 
perceptions to some extent based on the effects of frequency. These results may 
help health care providers in utilization of appropriate methods for communicating 
risk of medication side effects.
PIH66
develOPmenT Of A medIcATIOn-PrOBlem cOPIng scAle (mPcs) And ITems 
cAlIBrATIOn usIng One-PArAmeTer lOgIsTIc (1Pl) And TwO-PArAmeTer 
lOgIsTIc (2Pl) mOdels
Park T.
University of Minnesota, Minneapolis, MN, USA
objeCtives: Adverse drug problems (ADPs) have caused significant morbidity 
and mortality to patients. The objective of this study was to develop a medication-
problem coping scale (MPCS) to measure patients’ coping responses to their ADP 
and calibrate the developed items using one-parameter logistic (1PL) and two-
parameter logistic (2PL) models. Methods: A comprehensive literature review 
was conducted to identify candidate items to measure patient’s coping strategies 
when dealing with perceived ADPs. Supplementary items were then added to fill 
in the content gaps. The items were administered to patients in the community 
pharmacies which are incorporated into the Minnesota practice-based research 
network (PBRN). After collecting data from 140 patients, eleven items which met 
the assumptions of item response theory were calibrated using the 1PL and 2PL 
models respectively to determine which model is favored. Results: The 1PL and 
2PL model were compared by taking goodness-of-fit statistics, reliability of the 
estimated person scores, and standard error of measurement (SEM) into account. 
First, the chi-squared difference test was highly significant (X2(41.61, 10), P< 0.0001) 
indicating that the 2PL model provided a better fit to the item responses com-
pared to the 1PL model. This result was supported by the information-theoretic 
fit index (AIC) and the RMSEA value, all of which favored the 2PL model. In addi-
tion, the 2PL model was preferred with a higher value of score reliability esti-
mate (0.82) compared to that of the 1PL model (0.79). Finally, the 2PL model had 
much more information and much lower SEM over most of the coping behavior 
range. ConClusions: Our findings indicated that the 2PL model was preferred 
than the 1PL model. It suggests that the 2PL model be used to obtain item param-
eters and to assess information function.
Indonesia Demographic and Health Survey data of 2007 was obtained from Measured 
DHS using a randomized subset of 1,470 observations. Multinomial and binomial 
logistic regression were performed to assess assocations between long-term, short-
term and no contraception with wife’s age, wife’s education, husband’s education, 
number of children ever born, wife’s religion, wife’s working status, husband’s occupa-
tion, and wealth index. Results: Wife’s education, wealth index, number of children 
ever born, and wife’s age were statistically significant at the 95% CL. Overall, account-
ing for all categorical levels of wife’s education and wealth index both were statisti-
cally significant while the difference between each category were not statistically 
significant. The wife’s education at a secondary level (OR: 2.05; 95% CL, 1.26-3.35 ) was 
the most likely to choose any contraception (short or long term) while the wife with 
a wealth index (OR: 1.73; 95% CL, 1.24-2.42) at the third quintile was the most likely 
to choose any contraception (short or long term). Within contraception categories 
(short or long term), the wife with a higher education or in the top quintile of the 
wealth index was the most likely to choose short-term contraception. For long-term 
contraception, the wife with a secondary education and in the third quintile of wealth 
were more likely to choose that method. ConClusions: Wife’s education and wealth 
index indicate contraceptive choice. Between short-term and long-term contraceptive 
choice, wife’s education and wealth index increases are indicative for short-term but 
not for long-term warranting analysis of other socio-economic factors in association.
PIH62
A revIew Of fdA wArnIng leTTers And nOTIces Of vIOlATIOn Issued 
fOr PATIenT rePOrTed OuTcOmes PrOmOTIOnAl clAIms BeTween  
2006-2012
Symonds T.1, Hackford C.2, Abraham L.2
1Pfizer Ltd., Tadworth, Surrey, UK, 2Pfizer Ltd, Tadworth, Surrey, UK
objeCtives: To ascertain the frequency and types of PRO violations made in US 
pharmaceutical promotional materials between 2006 and 2012 and determine if 
there were increases in violation warnings following issuance of the FDA draft and 
final PRO guidance. Methods: Warning letters or notices of violation issued by the 
FDA’s Office of Prescription Drug Promotion (OPDP) were reviewed for PRO violations 
(n= 213). Type of violation was classified as: (1) PRO not fit for purpose; (2) Study 
design/Interpretation of results; (3) Statistical analysis; and/or (4) No Treatment 
benefit. Results: Of the 213 letters reviewed, 19% contained a PRO violation (n= 41); 
15 (37%) were warning letters and 26 (63%) were notice of violation letters. The 
most common violation was PRO not fit for purpose (54%) e.g. use of individual 
items (45%), content validity (36%), and broadening of the claim beyond what the 
PRO measures (27%). Issues with Study design/Interpretation of results were also 
high (49%), particularly broadening of claim beyond what was measured in the trial 
(55%), and no PRO used (50%). Fewer WLs/NOVs specified statistical issues (24%) but, 
most were because of lack of pre-specification of the analyses conducted (50%). 
Over half of the violations fell into more than one category (54%). PRO violations 
were issued across a wide array of therapeutic areas; pain drugs had the highest 
frequency (24%). Violations primarily occurred in professional sales and detail aids 
(22%), brochures (14%) and videos (11%). ConClusions: A fifth of letters issued to 
companies contained PRO violations with most of this related to poor selection of 
the PRO measure used or trying to broaden the claim. More guidance from OPDP 
about what is considered ‘substantial evidence’ in this area could help reduce the 
number of letters issued.
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gender dIfferences In cOgnITIve deBrIefIng Of TrAnslATed PATIenT 
QuesTIOnnAIres
Talbert M.1, Brandt B.A.2, McKown S.3, Gawlicki M.C.2, Schulz C.3
1Corporate Translations Inc., Chicago, IL, USA, 2Corporate Translations, Inc., East Hartford, CT, 
USA, 3Corporate Translations, Inc., Chicago, IL, USA
objeCtives: The objective of this study was to determine if any discernible differ-
ences, in quantity or content, exist in feedback from male and female subjects dur-
ing cognitive debriefing interviews of translated patient questionnaires. Methods: 
Cognitive debriefing took place with subjects diagnosed with Ulcerative Colitis, 
Stroke, COPD and Diabetes, across 54 different languages. Comments were clas-
sified as either those resulting in a translation revision made to improve compre-
hensibility, cultural appropriateness or grammar, or those leading to no revision, 
due to a stylistic suggestion or a source text deviation. The average number of 
comments made per subject was calculated for each classification, as well as a 
p value for the total using a two tailed t test. Results: Out of the total sample 
(n= 351), 171 respondents were male and 180 were female. The average number of 
comments made was 3.05 per male subject and 4.22 per female subject, with a p 
value of 0.006. For comments that resulted in a translation revision, per question-
naire, males averaged 0.95 comments and females averaged 1.19 comments, with a 
p value of 0.16. For comments that resulted in no revision, per questionnaire, males 
averaged 1.62 comments and females averaged 2.44 comments, with a p value of 
0.02. ConClusions: The results show that females, overall, make more comments 
during cognitive debriefing interviews than men. Additionally, females tend to make 
more comments that do not result in a translation revision, which may be stylistic 
or source deviation comments. For comments that result in a translation revision, 
there is no meaningful difference between males and females as demonstrated by 
the marginal difference between the two means and the p value. Both males and 
females contribute equally to ensuring a final translation is culturally appropriate 
and comprehensible.
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